Article
New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
BMC medical genomics - 7 May 2015
Kluska Anna, Balabas Aneta, Paziewska Agnieszka, Kulecka Maria, Nowakowska Dorota, Mikula Michal, Ostrowski Jerzy
Abstract excerpt
BACKGROUND: Targeted PCR-based genetic testing for BRCA1 and BRCA2 can be performed at a lower cost than full gene testing; however, it may overlook mutations responsible for familial breast and/or ovarian cancers. In the present study, we report the utility of next generation sequencing (NGS) to identify new pathogenic variants of BRCA1/2. METHODS: BRCA1 and BRCA2 exons were amplified using the Ion AmpliSeq...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
